We are live on ! Find out more
PWM

Perigon Wealth Management Portfolio holdings

AUM $5.51B
1-Year Est. Return 24.51%
This Fund
S&P 500
This Quarter Est. Return
+4.22%
1 Year Est. Return
+24.51%
3 Year Est. Return
+81.31%
5 Year Est. Return
+97.59%
10 Year Est. Return
+364.46%
AUM
$389M
AUM Growth
+$13.1M
Cap. Flow
+$659K
Cap. Flow %
0.17%
Top 10 Hldgs %
24.04%
Holding
655
New
214
Increased
174
Reduced
62
Closed
36

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$4.61M
2
AAPL icon
Apple
AAPL
+$1.64M
3
META icon
Meta Platforms (Facebook)
META
+$1.57M
4
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$1.35M
5
APTV icon
Aptiv
APTV
+$1.25M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$16.6M
2
TRV icon
Travelers Companies
TRV
+$5.43M
3
PFF icon
iShares Preferred and Income Securities ETF
PFF
+$2M
4
SCHX icon
Schwab US Large- Cap ETF
SCHX
+$1.59M
5
PFE icon
Pfizer
PFE
+$1.53M

Sector Composition

Rank Sector Weight
1 Healthcare 15.91%
2 Technology 12.71%
3 Communication Services 8.84%
4 Consumer Discretionary 8.54%
5 Financials 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBLY
151
DELISTED
Mobileye N.V.
MBLY
$492K 0.13%
11,550
+635
+6% +$29.4K
CGNX icon
152
Cognex
CGNX
$10.3B
$489K 0.13%
+18,508
New +$444K
SCHO icon
153
Schwab Short-Term US Treasury ETF
SCHO
$12.7B
$473K 0.12%
18,616
+692
+4% +$17.6K
EQIX icon
154
Equinix
EQIX
$108B
$454K 0.12%
+1,259
New +$467K
ALGN icon
155
Align Technology
ALGN
$12.1B
$448K 0.12%
4,778
+166
+4% +$15K
BMRN icon
156
BioMarin Pharmaceuticals
BMRN
$11.4B
$431K 0.11%
4,659
+536
+13% +$50.5K
REGN icon
157
Regeneron Pharmaceuticals
REGN
$69.1B
$419K 0.11%
1,041
-14
-1% -$5.62K
UA icon
158
Under Armour Class C
UA
$2.89B
$419K 0.11%
12,375
-843
-6% -$30.4K
SHY icon
159
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$417K 0.11%
4,908
+4,234
+628% +$360K
IGM icon
160
iShares Expanded Tech Sector ETF
IGM
$9.96B
$410K 0.11%
19,878
– –
DOC icon
161
Healthpeak Properties
DOC
$15.3B
$408K 0.1%
11,804
– –
IFF icon
162
International Flavors & Fragrances
IFF
$19.4B
$393K 0.1%
2,749
+175
+7% +$23.7K
IYR icon
163
iShares US Real Estate ETF
IYR
$4.59B
$392K 0.1%
4,867
+3,058
+169% +$253K
VIG icon
164
Vanguard Dividend Appreciation ETF
VIG
$111B
$392K 0.1%
4,671
+3,271
+234% +$277K
FAST icon
165
Fastenal
FAST
$53.8B
$384K 0.1%
36,792
+2,168
+6% +$23.1K
MJN
166
DELISTED
Mead Johnson Nutrition Company
MJN
$372K 0.1%
4,699
+189
+4% +$16.1K
TTC icon
167
Toro Company
TTC
$8.89B
$371K 0.1%
7,919
+567
+8% +$26.5K
VEA icon
168
Vanguard FTSE Developed Markets ETF
VEA
$226B
$371K 0.1%
9,930
-482
-5% -$17.7K
XHS icon
169
State Street SPDR S&P Health Care Services ETF
XHS
$205M
$364K 0.09%
+6,612
New +$373K
DNY
170
DELISTED
DONNELLEY R R & SONS CO
DNY
$362K 0.09%
23,000
– –
PG icon
171
Procter & Gamble
PG
$342B
$353K 0.09%
3,938
+1,250
+47% +$109K
QQQ icon
172
Invesco QQQ Trust
QQQ
$455B
$336K 0.09%
+2,820
New +$325K
SMG icon
173
ScottsMiracle-Gro
SMG
$4.03B
$333K 0.09%
4,000
– –
SCHW
174
Charles Schwab
SCHW
$176B
$328K 0.08%
10,380
– –
ADBE icon
175
Adobe
ADBE
$89.5B
$318K 0.08%
2,930
– –
5 6
7
8 9

Similar funds

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return
SWP
Sagespring Wealth Partners Franklin, Tennessee $5.49B AUM 19.47% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DWA
Douglass Winthrop Advisors New York $5.46B AUM 11.49% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return

Perigon Wealth Management's Q3 2016 Portfolio in Review

As of Q3 2016, Perigon Wealth Management held 655 positions worth $389M, up 3.5% from $376M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Perigon Wealth Management's Q3 2016 filing shows 214 new, 174 increased, 62 reduced and 36 closed positions. Its largest new stake was Amgen: 27,286 shares worth $4.55M. The largest sale was Merck, an estimated $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 20% a quarter earlier, followed by Technology and Communication Services.

  • Perigon Wealth Management's largest Q3 2016 buy was Amgen: 27,286 shares worth $4.55M.
  • Perigon Wealth Management added most to Apple in Q3 2016, an estimated $1.64M increase.
  • Perigon Wealth Management's biggest Q3 2016 reduction was Merck, cutting an estimated $16.6M.
  • Perigon Wealth Management fully exited Travelers Companies in Q3 2016, selling an estimated $5.43M.
  • Perigon Wealth Management's ten largest holdings make up 24% of its $389M portfolio in Q3 2016.
  • Perigon Wealth Management opened 214 new positions and closed 36 in Q3 2016.
  • Perigon Wealth Management's portfolio value rose 3.5% quarter-over-quarter to $389M.

Based on Perigon Wealth Management's 13F filing for Q3 2016, filed 16 Nov 2016.